| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 387 | 587 | 54 | | Cost of Revenue | 126 | 305 |
-
| | | Gross Profit | 261 | 282 | 54 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,046 | 6,118 | 8,181 | | Non Recurring | 10,865 | 19,599 | 1,281 | | Others | 239 | 482 | 63 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,889) | (25,917) | (9,471) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,795 | 6,575 | 17,458 | | Earnings Before Interest And Taxes | (10,095) | (19,341) | 7,988 | | Interest Expense | 3,676 | 10,259 | 12,270 | | Income Before Tax | (13,770) | (29,601) | (4,282) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,770) | (29,601) | (4,282) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,770) | (29,601) | (4,282) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,770) | ($29,601) | ($4,282) |
|
0.51% Nasdaq 
Income Statement
